CompoAtlas

DORMALINE

Food supplement declared in France, declaration No 2016-9-169, decision dated 7 September 2016

DORMALINE (VALEMIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
VALEMIS
Food business operator placing the product on the market
VALEMIS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Spray
Daily dose
3 spay/0,3 ml
Directions for use
avant le voyage ou le coucher
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement antihypertenseur
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil
Flavourings
Fleurs d'oranger

Declaration 275930, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Citrus aurantium L.FleurHydrolât (eau florale)290.3 mg
Melissa officinalis L.FeuilleExtrait fluide hydroalcoolique6 mg

Other active ingredients

NamePer day
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E415, E330, E202, E211, E960

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux enfants, femmes enceintes et allaitantes et en cas de traitement anti-hypertenseur

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : VALEMIS

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line